Showing results (21-30 of 127) with videos related to

Sort By:
Pageof 13
Journal of Clinical Microbiology|November 1, 1975
Selective medium for growth of ProteusM E Xilinas, J T Papavassiliou, N J Legakis
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 1, 1996
Variable antifungal susceptibility of wild-type Candida albicans phenotypes from neutropenic hostsA Velegraki, D Papalambrou, S Soremi, et al.
Annales De Microbiologie|September 1, 1982
Outer membrane proteins in a carbenicillin-resistant strain of Pseudomonas aeruginosaH A Pataryas, N J Legakis, K Sekeri-Pataryas
Chemotherapy|July 29, 1998
In vitro activity of loracarbef against TEM extended-spectrum beta-lactamase-producing Escherichia coli strains and its interaction with the enzymesE E Prinarakis, L S Tzouvelekis, N J Legakis
Chemotherapy|January 1, 1984
Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patientsC Costopoulos, N J Legakis, E Papafragas, et al.
Journal of Clinical Microbiology|December 1, 1994
Antibiotic resistance of clinical isolates of Streptococcus pneumoniae in GreeceS Kanavaki, S Karabela, E Marinis, et al.
Journal of Medical Microbiology|August 1, 1978
Differentiation of Serratia marcescens and Serratia liquefaciens by tests for lipase and phospholipase productionN J Legakis, K J Nicolas, M Xilinas, et al.
FEMS Microbiology Letters|March 12, 1998
Substitution of Arg-244 by Cys or Ser in SHV-1 and SHV-5 beta-lactamases confers resistance to mechanism-based inhibitors and reduces catalytic efficiency of the enzymesP Giakkoupi, E Tzelepi, N J Legakis, et al.
Chemioterapia : International Journal of the Mediterranean Society of Chemotherapy|June 1, 1986
Survey of aminoglycoside resistance patternsN J Legakis, A Velonaki, E M Velonakis, et al.
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamasesP Giakkoupi, E Tzelepi, N J Legakis, et al.
Pageof 13